![Clinical Effects of Inhibiting Leukocyte Adhesion with Monoclonal Antibody to Intercellular Adhesion Molecule-1 (Enlimomab) in the Treatment of Partial-Thickness Burn Injury]()
Clinical Effects of Inhibiting Leukocyte Adhesion with Monoclonal Antibody to Intercellular Adhesion Molecule-1 (Enlimomab) in the Treatment of Partial-Thickness Burn InjuryMileski, William J.; Burkhart, Deborah; Hunt, John L.; Kagan, Richard J.; Saffle, Jeffrey R.; Herndon, David N.; Heimbach, David M.; Luterman, Arnold; Yurt, Roger W.; Goodwin, Cleon W.; Hansborough, John · The Journal of Trauma: Injury, Infection, and Critical Care · 2003